seekingalpha.com /1 week ago

Viridian Therapeutics, Inc. (VRDN) Discusses VRDN-008 Phase I Results and FcRn Portfolio Development Plans - Slideshow

Read source
seekingalpha.com /3 weeks ago

Verano Holdings Corp. reports Q3 results

Read source
investing.com /2 weeks ago

Viridian to present phase 1 data for VRDN-008 on Monday

Read source
newswire.com /2 weeks ago

OSR Health Exercises $15 Million VXM01 Equity Option, Elects Settlement Through Staged Convertible Notes

Note purchase targeted to close by December 31, 2026; roadmap update on OSRK reverse takeover discussions, OTCQB uplisting and VXM01 manuscript

Read source
seekingalpha.com /2 weeks ago

Enviri Corporation (NVRI) Q3 2026 Earnings Call Transcript

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.